Physician profile
Sonya Marcus
NPI 1437594058
$9,907.89
in general payments reported to CMS, 2019-2025
14 companies · $1,726 in 2025
The $1,726 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $854 · 2022: $4,379 · 2023: $740 · 2024: $1,948 · 2025: $1,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,648 · Food and Beverage: $1,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,648.00 |
| Food and Beverage | $1,766.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,000.00 | 2022 | |
| Genzyme Corporation | $2,814.45 | 2023-2025 | |
| Aerin Medical INC. | $1,163.38 | 2022-2025 | |
| Stryker Corporation | $937.48 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $299.10 | 2023-2024 | Dupixent |
| Optinose US, INC. | $281.51 | 2019-2024 | |
| Integra Lifesciences Corporation | $184.52 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Carestream Dental, LLC | $62.03 | 2024 | |
| Acclarent, INC | $29.83 | 2020 | |
| Smith+Nephew, INC. | $15.37 | 2020 | |
| Hikma Pharmaceuticals USA | $13.58 | 2025 | Ryaltris |
| Alk-Abello, INC | $11.43 | 2019 | |
| Karl Storz Endoscopy-America | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.